[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grants-domain-organoids-3d-models":3},{"grants":4,"total":70,"limit":71,"offset":72},[5,28,46,51],{"id":6,"name":7,"funder":8,"budget":9,"budget_min_eur":10,"budget_max_eur":11,"budget_high_priority":12,"duration":13,"deadline":14,"deadline_note":15,"trl":16,"relevance":10,"why_relevant":10,"early_career":12,"consortium":17,"link":18,"first_seen":19,"last_updated":20,"update_note":10,"status":21,"stages":22,"call_frequency":10,"next_call_expected":10,"source_url":18,"created_at":23,"updated_at":24,"eligible_countries":25,"seo_summary":10,"seo_summary_hash":10,"description":27},"kwf-kankerbestrijding-boost-bridging-obstacles-for-optimal-model-use-via-2026-07","BOOST (Bridging Obstacles for Optimal model use via Shared Technical expertise)","KWF Kankerbestrijding","~€150,000 per project",null,150000,false,"6-24 months","2026-07-01T00:00:00.000Z","Deadline inferred from reference to 1 July 2026 cut-off; participating institutes not yet registered must submit registration request at least 6 weeks prior to closing date","3+","No","https:\u002F\u002Fwww.kwf.nl\u002Fen\u002Fforresearchers\u002Ffunding\u002Fboost","2026-04-27T00:00:00.000Z","2026-04-29T00:00:00.000Z","open","Single stage: full-proposal only","2026-04-27T13:58:44.162Z","2026-04-29T04:20:58.422Z",[26],"NL","Open to researchers with an ongoing or recently finished KWF drug research project (start ≥6 months ago, end ≤1.5 years before 1 July 2026). Funds access to clinically relevant preclinical models, technologies and expertise (e.g. NAMs, PDX, organoids, CROs) to improve translational value. Dutch institutions only; commercial partner involvement requires a letter of intent.",{"id":29,"name":30,"funder":31,"budget":32,"budget_min_eur":33,"budget_max_eur":34,"budget_high_priority":12,"duration":35,"deadline":36,"deadline_note":37,"trl":38,"relevance":10,"why_relevant":10,"early_career":12,"consortium":39,"link":40,"first_seen":41,"last_updated":10,"update_note":10,"status":21,"stages":42,"call_frequency":43,"next_call_expected":44,"source_url":40,"created_at":45,"updated_at":45,"eligible_countries":10,"seo_summary":10,"seo_summary_hash":10,"description":10},"health-holland-health-holland-organ-on-chip-call-2026-2026-09","Health~Holland Organ-on-Chip Call 2026","Health~Holland","PPP subsidy",300000,1000000,"2-3 years","2026-09-22T00:00:00.000Z","Organ-on-chip technology PPP","Applied","Required — PPP","https:\u002F\u002Fwww.health-holland.com\u002Ffunding-opportunities\u002Forgan-chip-call","2026-03-22T00:00:00.000Z","Single stage","Annual","2027-03","2026-03-22T16:26:02.419Z",{"id":47,"name":30,"funder":31,"budget":32,"budget_min_eur":33,"budget_max_eur":34,"budget_high_priority":12,"duration":35,"deadline":36,"deadline_note":37,"trl":38,"relevance":10,"why_relevant":10,"early_career":12,"consortium":39,"link":40,"first_seen":41,"last_updated":48,"update_note":10,"status":21,"stages":42,"call_frequency":43,"next_call_expected":44,"source_url":40,"created_at":49,"updated_at":50,"eligible_countries":10,"seo_summary":10,"seo_summary_hash":10,"description":10},"health-holland-organ-chip-2026","2026-03-23T00:00:00.000Z","2026-03-22T19:42:46.890Z","2026-03-23T13:26:24.584Z",{"id":52,"name":53,"funder":54,"budget":55,"budget_min_eur":56,"budget_max_eur":57,"budget_high_priority":12,"duration":10,"deadline":58,"deadline_note":59,"trl":60,"relevance":10,"why_relevant":10,"early_career":12,"consortium":61,"link":62,"first_seen":63,"last_updated":19,"update_note":10,"status":21,"stages":64,"call_frequency":65,"next_call_expected":10,"source_url":62,"created_at":66,"updated_at":67,"eligible_countries":68,"seo_summary":10,"seo_summary_hash":10,"description":69},"health-holland-eureka-biotech-call-2026","Eureka Biotech Call 2026","Health Holland","€400k–€750k per project (Dutch partners)",400000,750000,"2026-09-25T00:00:00.000Z","Central EUREKA submission + national documentation required; Dutch consortia encouraged to notify RVO and Health Holland in advance","4-7","Required — at least 2 Dutch partners (1 company + 1 research organisation) and at least 2 partners from a priority country (1 company + 1 research organisation); priority countries: Belgium, France, Germany, Singapore, Spain, Sweden, Switzerland","https:\u002F\u002Fwww.health-holland.com\u002Ffunding-opportunities\u002Feureka-biotech-call-2026","2026-04-12T00:00:00.000Z","2-stage: central EUREKA submission portal, then national submission portal","One-off","2026-04-12T04:22:44.300Z","2026-04-27T13:58:46.312Z",[26],"PPP subsidy for Dutch SMEs and research organisations participating in international R&D consortia focused on cell and gene therapies (CGT) and Organ-on-Chip (OoC) technologies (TRL 4–7). Healthcare providers and foundations are not eligible. International partners must secure their own funding. Co-funding (in-kind and\u002For cash) by all partners is required.",4,50,0]